Summary
In a wide variety of tumor types, the expression of stromelysin 1 which is one of the matrix metalloproteinases (MMPs) has been shown to correlate with tumor invasion. However, little is known about the distribution of stromelysin in human brain tumors. We have previously shown that a correlation exists between the type IV collagenases, tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 transcripts and in vitro invasiveness among 7 human astrocytoma cell lines. In the present study, we analyzed the expression of stromelysin 1 among the same panel of human astrocytoma cell lines and human fibroblasts by northern blot analyses and in situ hybridization. Northern blot analysis demonstrated that SF-126 and U87 MG expressed high level stromelysin 1 transcripts. Following heat shock stimulation, the stromelysin 1 transcript was up-regulated in U87 MG astrocytoma cells. In situ hybridization analysis showed specific intracytoplasmic localization of mRNA for stromelysin in these astrocytoma cell lines. By casein zymography, we have determined that both SF-126 and U87 MG secreted stromelysin 1 protein. We conclude that stromelysin 1 is expressed by certain human astrocytoma cell lines, and this study confirms the importance of continuing to characterize the proteolytic enzyme profile of these tumors to fully understand the molecular mechanisms involved in astrocytoma invasiveness.
Similar content being viewed by others
References
Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327–336, 1991
Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. TIG 6: 121–125, 1990
Matrisian LM: The matrix-degrading metalloproteinases. Bio Essays 14: 455–463, 1992
Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, Banda MJ: Expression of metalloproteinases and metalloproteinase inhibitor by fetal astrocytoma and glioma cells. Cancer Res 50: 2322–2329, 1990
Halaka AN, Bunning RAD, Bird CC, Gibson M, Reynolds JJ: Production of collagenase and inhibitor (TIMP) by intracranial tumors and dura in vitro. J Neurosurg 59: 461–466, 1983
Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y: Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69–77, 1994
Nakano A, Tani E, Miyazaki K, Furuyama J, Matsumoto T: Expression of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Commun 192: 999–1003, 1993
Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R: Elevated levels of Mr 92,000 type IV collagenase in human brain tumors. Cancer Res 53: 2208–2211, 1993
Rutka JT, Hubbard SL, Fukuyama K, Matsuzawa K, Becker LE, Stetler-Stevenson W, Dirks PB: Expression of TIMP-1, TIMP-2, 72- and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: Correlation with astrocytoma cell invasiveness. Int J Oncology 6: 877–884, 1995
Chin JR, Murphy G, Werb Z: Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. J Biol Chem 260: 12367–12376, 1985
Saus J, Quinones S, Otani Y, Nagase H, Harris ED Jr, Kurkinen M: The complete primary structure of human matrix metalloproteinase-3. J Biol Chem 263: 6742–6745, 1988
Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z: Secretion of metalloproteinases by stimulated capillary endothelial cells. J Biol Chem 261: 2814–2818, 1986
Goldberg GI, Strongin A, Collier IE, Genrich T, Marmer BL: Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267: 4583–4591, 1992
Miyazaki K, Umenishi F, Funahashi K, Koshikawa N, Yasumitsu H, Umeda M: Activation of TIMP-2/progelatinase A complex by stromelysin. Biochem Biophys Res Commun 185: 852–859, 1992
Ogata Y, Enghild JJ, Nagase H: Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267: 3581–3584, 1992
Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H: Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29: 10261–10270, 1990
Rutka JT, Giblin JR, Hoifodt HK, Dougherty DV, Bell CW, McCulloch JR, Davis RL, Wilson CB, Rosenblum ML: Establishment and characterization of a cell line from a human gliosarcoma. Cancer Res 46: 5893–5901, 1986
Rutka JT, Giblin JR, Dougherty DV, Liu HC, McCulloch JR, Bell CW, Stem RS, Wilson CB, Rosenblum ML: Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol 75: 92–103, 1987
Carlson J, Nilsson K, Westermark B: Formation and growth of multicellular spheroids of human origin. Int J Cancer 31: 523–533, 1983
Ponten J, Macintyre EH: Long-term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74: 465–486, 1968
Ponten J, Westermark B: Properties of human malignant glioma cells in vitro. Medical Biology 56: 184–193, 1978
Westermark B, Ponten J, Hugosson R: Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand 81: 791–805, 1973
Vance BA, Kowalski CG, Brinckerhoff CE: Heat shock of rabbit synovial fibroblasts increases expression of mRNAs for two metalloproteinases, collagenase and stromelysin. J Cell Biol 108: 2037–2043, 1989
Chomczynski P, Sacchi N: Single step method of mRNA isolation by acid guanidinium thiocyanide-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987
Declerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM: Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701–708, 1992
Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102: 196–202, 1980
Lokeshwar BL, Selzer MG, Block NL, Gunja-Smith Z:Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: Reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res 53: 4493–4498, 1993
Laemmli UK: Cleavage of stractual proteins during the assembly of the head of bacteriophage T4. Nature (Loud) 227: 680–685, 1970
Frisch SM, Ruley HE: Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 262: 16300–16304, 1987
Quinones S, Saus J, Otani Y, Harris ED Jr, Kurkinen M: Transcriptional regulation of stromelysin. J Biol Chem 264: 8339–8344, 1989
Umenishi F, Yasumitsu H, Ashida Y, Yamauchi J, Umeda M, Miyazaki K: Purification and properties of extracellular matrix-degrading metallo-proteinase overproduced by tons sarcoma virus-transformed rat liver cell line, and its identification as transin. J Biochem 108: 537–543, 1990
Delany AM, Brinckerhoff CE: Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J Cell Biochem 50: 400–410, 1992
Kataoka H, DeCastro R, Zucker S, Biswas C: Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 53: 3154–3158, 1993
Brinckerhoff CE, McMillan RM, Fahey JV, Harris ED Jr: Collagenase production by synovial cells treated with phorbol myristate acetate. Arthritis Rheum 22: 1109–1116, 1979
Matrisian KM, McDonnell S, Miller DB, Navre M, Seftor Ba EA, Hendrix MJC: The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinoma. Am J Med Sci 302: 157–162, 1991
Ostrowski LE, Finch J, Krieg P, Matrisian L, Patskan G, O'Connell JF, Phillips J, Slaga TJ, Breathnach R, Bowden GT. Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression. Mol Carcinogenesis 1: 13–19, 1988
Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S, Pozzatti RO: Expression of matrix metalloproteinase gene in transformed rat cell lines of high and low metastatic potential. Cancer Res 52: 4942–4947, 1992
Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler-Stevenson WG: Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 83: 775–779, 1991
Yang TT, Hawkes SP: Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci USA 89: 10676–10680, 1992
Matrisian LM, Bowden GT, Krieg P, Furstenberger G, Briand J-P, Leroy P, Breathnach R: The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci USA 83: 9413–9417, 1986
Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, Seiki M: Expression of gene encoding type IV collagen-degrading metalloproteinases in various human tumor cells. Oncogene 7: 77–83, 1992
Wright J, McDonnell S, Matrisian LM: Stromelysin-1 is expressed in stromal cells as well as keratinocytes in the mouse skin model of two-stages carcinogenesis. Proc AACR 34: 174, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsuzawa, K., Fukuyama, K., Dirks, P.B. et al. Expression of stromelysin 1 in human astrocytoma cell lines. J Neuro-Oncol 30, 181–188 (1996). https://doi.org/10.1007/BF00177269
Issue Date:
DOI: https://doi.org/10.1007/BF00177269